Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PRGO Stock Forecast 2025-2026
$27.01
Current Price
$3.71B
Market Cap
Buy 3
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to PRGO Price Targets
+55.5%
To High Target of $42.00
+29.6%
To Median Target of $35.00
0.0%
To Low Target of $27.00
PRGO Price Momentum
+7.0%
1 Week Change
+9.6%
1 Month Change
-12.0%
1 Year Change
+5.1%
Year-to-Date Change
-13.8%
From 52W High of $31.32
+16.7%
From 52W Low of $23.14
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Perrigo (PRGO) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on PRGO and similar high-potential opportunities.
Latest PRGO Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, PRGO has a neutral consensus with a median price target of $35.00 (ranging from $27.00 to $42.00). The overall analyst rating is Buy (7.3/10). Currently trading at $27.01, the median forecast implies a 29.6% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Susan Anderson at Canaccord Genuity, projecting a 55.5% upside. Conversely, the most conservative target is provided by Korinne Wolfmeyer at Piper Sandler, suggesting a 0.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PRGO Analyst Ratings
3
Buy
3
Hold
0
Sell
PRGO Price Target Range
Low
$27.00
Average
$35.00
High
$42.00
Current: $27.01
Latest PRGO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PRGO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 6, 2025 | Piper Sandler | Korinne Wolfmeyer | Neutral | Downgrade | $27.00 |
| Sep 30, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $42.00 |
| Sep 23, 2024 | Jefferies | Keith Devas | Hold | Downgrade | $30.00 |
| Jul 11, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $35.00 |
| Jun 13, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $36.00 |
| Apr 12, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $42.00 |
| Apr 8, 2024 | Piper Sandler | Korinne Wolfmeyer | Overweight | Maintains | $39.00 |
| Feb 28, 2024 | JP Morgan | Chris Schott | Overweight | Maintains | $41.00 |
| Nov 17, 2023 | Piper Sandler | Korinne Wolfmeyer | Overweight | Initiates | $37.00 |
| Aug 9, 2023 | JP Morgan | Chris Schott | Overweight | Maintains | $48.00 |
| Mar 7, 2023 | Canaccord Genuity | Susan Anderson | Buy | Initiates | $49.00 |
| Mar 6, 2023 | Raymond James | Elliot Wilbur | Outperform | Maintains | $43.00 |
| Nov 9, 2022 | Raymond James | Elliot Wilbur | Outperform | Maintains | $42.00 |
| Sep 14, 2022 | Argus Research | Kristina Ruggeri | Buy | Upgrade | $46.00 |
| Sep 6, 2022 | Wells Fargo | Jacob Hughes | Overweight | Upgrade | $54.00 |
| May 4, 2022 | Raymond James | Elliot Wilbur | Outperform | Maintains | $48.00 |
| Nov 11, 2021 | Raymond James | Elliot Wilbur | Outperform | Maintains | $55.00 |
| Oct 14, 2021 | Raymond James | Outperform | Upgrade | $0.00 | |
| Sep 30, 2021 | Jefferies | David Steinberg | Buy | Upgrade | $63.00 |
| Mar 5, 2021 | Morgan Stanley | David Risinger | Equal-Weight | Maintains | $45.00 |
Perrigo Company plc (PRGO) Competitors
The following stocks are similar to Perrigo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Perrigo Company plc (PRGO) Financial Data
Perrigo Company plc has a market capitalization of $3.71B with a P/E ratio of 2,818.0x. The company generates $4.34B in trailing twelve-month revenue with a -4.2% profit margin.
Revenue growth is -3.5% quarter-over-quarter, while maintaining an operating margin of +7.6% and return on equity of -3.6%.
Valuation Metrics
Market Cap
$3.71B
Enterprise Value
$6.91B
P/E Ratio
2,818.0x
PEG Ratio
8.7x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
-3.5%
Gross Margin
+37.6%
Operating Margin
+7.6%
Net Margin
-4.2%
EPS Growth
-3.5%
Financial Health
Cash/Price Ratio
+11.0%
Current Ratio
2.4x
Debt/Equity
83.1x
ROE
-3.6%
ROA
+3.1%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Perrigo Company plc (PRGO) Business Model
About Perrigo Company plc
What They Do
Global provider of OTC consumer healthcare products.
Business Model
Perrigo generates revenue by manufacturing and distributing over-the-counter healthcare products, including vitamins, dietary supplements, and personal care items. The company focuses on offering affordable alternatives to brand-name drugs, which broadens its consumer base and enhances accessibility to health products.
Additional Information
Headquartered in Dublin, Ireland, Perrigo operates worldwide and collaborates with healthcare institutions and retail channels. The company is known for its commitment to innovation and quality, continuously evolving its product offerings to meet consumer needs and regulatory standards, thus playing a vital role in improving public health.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,140
CEO
Mr. Patrick Lockwood-Taylor
Country
Ireland
IPO Year
1991
Website
www.perrigo.comPerrigo Company plc (PRGO) Latest News & Analysis
Latest News
Quick Summary
Perrigo Company plc will hold its Q1 2025 Earnings Conference Call on May 7, 2025, at 8:30 AM ET, featuring key executives and analysts from various firms.
Why It Matters
Perrigo's Q1 earnings call provides insights into its financial health and strategic direction, critical for assessing investment potential and market confidence.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Perrigo reported Q1 2025 net sales of $1.04 billion, down 3.5% mainly from divestitures and currency impacts. Adjusted EPS growth and margin expansion were driven by infant formula and OTC brands.
Why It Matters
Perrigo's plan and EPS growth signal operational resilience, but declining sales and macroeconomic uncertainty raise concerns about future performance, impacting investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
PRGO's Q1 revenue is expected to be affected by divested businesses and product lines, as well as adverse currency fluctuations.
Why It Matters
PRGO's revenue decline due to exited businesses and currency issues signals potential volatility and risk, affecting future earnings and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Negative
Perrigo (PRGO) Q1 Earnings Beat Estimates
5 days ago
Quick Summary
Perrigo (PRGO) reported Q3 earnings of $0.60 per share, exceeding the Zacks estimate of $0.56, and up from $0.29 per share year-over-year.
Why It Matters
Perrigo's quarterly earnings beat expectations and show substantial year-over-year growth, indicating strong performance and potential for future profitability, which can boost investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Perrigo's (PRGO) financial results for Q1 2025 should be evaluated against Wall Street estimates and prior year metrics for a clearer performance assessment.
Why It Matters
Key metrics versus Wall Street estimates and year-ago values indicate Perrigo's performance trends, impacting future valuation and investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
PRGO's Q1 2025 results show a revenue decline, primarily attributed to lost sales from exited businesses and product lines.
Why It Matters
PRGO's declining sales from exited businesses signal potential long-term challenges, affecting revenue growth and investor confidence in future performance.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About PRGO Stock
What is Perrigo Company plc's (PRGO) stock forecast for 2025?
Based on our analysis of 17 Wall Street analysts, Perrigo Company plc (PRGO) has a median price target of $35.00. The highest price target is $42.00 and the lowest is $27.00.
Is PRGO stock a good investment in 2025?
According to current analyst ratings, PRGO has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.01. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PRGO stock?
Wall Street analysts predict PRGO stock could reach $35.00 in the next 12 months. This represents a 29.6% increase from the current price of $27.01. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Perrigo Company plc's business model?
Perrigo generates revenue by manufacturing and distributing over-the-counter healthcare products, including vitamins, dietary supplements, and personal care items. The company focuses on offering affordable alternatives to brand-name drugs, which broadens its consumer base and enhances accessibility to health products.
What is the highest forecasted price for PRGO Perrigo Company plc?
The highest price target for PRGO is $42.00 from Susan Anderson at Canaccord Genuity, which represents a 55.5% increase from the current price of $27.01.
What is the lowest forecasted price for PRGO Perrigo Company plc?
The lowest price target for PRGO is $27.00 from Korinne Wolfmeyer at Piper Sandler, which represents a 0.0% decrease from the current price of $27.01.
What is the overall PRGO consensus from analysts for Perrigo Company plc?
The overall analyst consensus for PRGO is neutral. Out of 17 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $35.00.
How accurate are PRGO stock price projections?
Stock price projections, including those for Perrigo Company plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 12, 2025 4:45 AM UTC